How much revenue does Abattis Bioceuticals make?

Abattis Bioceuticals reported 356,876 CAD in revenue for fiscal year 2019, up 4163.2% from 8,371 CAD in fiscal year 2018.

What companies are similar to Abattis Bioceuticals?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Immage Biotherapeutics Corp. (IMMG), Halo Collective Inc. (HCANF), MPX International Corporation (MPXOF), Golden Developing Solutions, Inc. (DVLP).

Abattis Bioceuticals Corp. (ATTBF) Stock

About Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the canna...

At a glance

Abattis Bioceuticals reported revenue of 356,876 CAD for fiscal year 2019, up 4163.2% from fiscal year 2018, and net income of -3.04 million CAD.

Figures from company filings; latest fiscal year ended September 30, 2019.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.